197 related articles for article (PubMed ID: 3870462)
1. Influence of intensive induction and consolidation therapy in acute lymphoblastic leukaemia in children.
Sanchetee SC; Pai SK; Pai VR; Kurkure PA; Shetty PA
Indian J Cancer; 1985 Sep; 22(3):217-20. PubMed ID: 3870462
[No Abstract] [Full Text] [Related]
2. [Study on the treatment of acute lymphoblastic leukemia with T-cell markers in children].
Nishikawa A; Saito K; Taniuchi S; Ohnishi T; Matsumura T
Rinsho Ketsueki; 1984 May; 25(5):660-5. PubMed ID: 6332214
[No Abstract] [Full Text] [Related]
3. [Results of the treatment of lymphoblastic leukemia by the BFM program in children--a 5-year observation].
Rokicka-Milewska R; Derulska D; Makowska K; Skwarska E; Lewicki Z
Acta Haematol Pol; 1987; 18(1-2):1-8. PubMed ID: 3481150
[No Abstract] [Full Text] [Related]
4. [Consolidating chemotherapy in the treatment program of acute lymphoblastic leukemia in children].
Maiakova SA; Makhonova LA
Vestn Akad Med Nauk SSSR; 1986; (5):15-7. PubMed ID: 3487897
[No Abstract] [Full Text] [Related]
5. [Remission induction and maintenance with multi-drug regimen (modified LSA2L2) for acute lymphoblastic leukemia in children].
Shitara T; Kuribayashi T; Oshima Y; Hiraishi Y
Rinsho Ketsueki; 1983 Nov; 24(11):1479-83. PubMed ID: 6584649
[No Abstract] [Full Text] [Related]
6. [Cerebellar infarction following remission induction therapy in acute lymphoblastic leukemia].
Aoki Y; Shibuya A; Ninomiya H; Nakazawa M; Nakamura H; Kageoka T; Nagasawa T; Yoda Y; Abe T
Rinsho Ketsueki; 1987 Apr; 28(4):624-8. PubMed ID: 3476768
[No Abstract] [Full Text] [Related]
7. Acute lymphoblastic leukaemia presenting as breast mass.
Jain AK; Gupta RC; Bhardwaj B; Leelani N
J Assoc Physicians India; 1992 May; 40(5):335-6. PubMed ID: 1483996
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of acute lymphoblastic leukemia in adults using the 08 LA 74 and RALL 81 A protocols].
Colović M; Petrović M; Janković G; Janosević S; Jancić M
Srp Arh Celok Lek; 1988 Mar; 116(3):227-33. PubMed ID: 3166210
[No Abstract] [Full Text] [Related]
9. [Results of the CCLSG high risk ALL 874 protocol in childhood acute lymphoblastic leukemia. Children's Cancer and Leukemia Study Group].
Kawai S; Fujimoto T; Zha Z; Asami K; Oka T; Kaneko Y; Takaue Y; Ninomiya T; Nishikawa K; Tsuchiya T
Rinsho Ketsueki; 1993 Feb; 34(2):128-36. PubMed ID: 8492409
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of acute lymphoblastic leukemia in adults by a modified L-10M protocol (Sloan-Kettering)].
Kuriyama K; Maeda T; Atogami S; Itoyama T; Tsukasaki K; Kohno T; Sasagawa I; Moriuchi Y; Nakamura H; Toriya K
Rinsho Ketsueki; 1986 Dec; 27(12):2267-73. PubMed ID: 3471978
[No Abstract] [Full Text] [Related]
11. Intermediate dose methotrexate (IDM) in children with acute lymphocytic leukemia (ALL). An update.
Freeman AI
Sangre (Barc); 1985; 30(6):1007-33. PubMed ID: 3913034
[No Abstract] [Full Text] [Related]
12. [Treatment of acute lymphoblastic leukemia in children: modified LSA2-L2 therapy].
Ishii E; Hara T; Ueda K; Kishida K; Nakamura E; Miyazaki S; Yoshida N
Rinsho Ketsueki; 1985 Apr; 26(4):487-93. PubMed ID: 3862888
[No Abstract] [Full Text] [Related]
13. [Results of treatment of children with lymphoblastic leukemia in relation to the methods of therapy].
Litwiniszyn-Krzewicka K; Sarzyńska M
Wiad Lek; 1987 Jan; 40(1):8-12. PubMed ID: 3473797
[No Abstract] [Full Text] [Related]
14. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
Matsuzaki A; Ishii E; Okamura J; Eguchi H; Yoshida N; Yanai F; Inoue T; Miyake K; Ishihara T; Tsuboi C
Med Pediatr Oncol; 1996 Jan; 26(1):10-9. PubMed ID: 7494507
[TBL] [Abstract][Full Text] [Related]
15. Induction toxicity of a modified Memorial Sloan-Kettering-New York II Protocol in children with relapsed acute lymphoblastic leukemia: a single institution study.
Morland BJ; Shaw PJ
Med Pediatr Oncol; 1996 Sep; 27(3):139-44. PubMed ID: 8699989
[TBL] [Abstract][Full Text] [Related]
16. Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia.
Sallan SE; Hitchcock-Bryan S; Gelber R; Cassady JR; Frei E; Nathan DG
Cancer Res; 1983 Nov; 43(11):5601-7. PubMed ID: 6352020
[TBL] [Abstract][Full Text] [Related]
17. [Modified VAPA therapy in children with acute nonlymphocytic leukemia].
Morohashi F; Aonuma K; Katoh M; Kobayashi T; Hanaoka Y; Tsuji K; Norose N; Kawai H; Nakahata T; Tsukada M
Rinsho Ketsueki; 1986 Nov; 27(11):2101-6. PubMed ID: 3820627
[No Abstract] [Full Text] [Related]
18. [A case of acute T lymphoblastic leukemia with suppressor function].
Takeichi N; Inoue T; Simamoto Y; Sato H; Umemura T; Kaneko S; Nishimura J; Motomura S; Ibayashi H
Rinsho Ketsueki; 1984 Apr; 25(4):561-7. PubMed ID: 6236312
[No Abstract] [Full Text] [Related]
19. [Results of 2 chemotherapy protocols (VPA and C-VPA) in acute adult lymphoblastic leukemia].
Avilés Miranda A; Ambriz Fernández R; Díaz Maqueo JC; Mascaró Sacristán J; Sinco Angeles A; Pizzuto J
Rev Invest Clin; 1983; 35(4):285-9. PubMed ID: 6369467
[No Abstract] [Full Text] [Related]
20. Post-induction residual disease in translocation t(12;21)-positive childhood ALL.
Seyfarth J; Madsen HO; Nyvold C; Ryder LP; Clausen N; Jonmundsson GK; Wesenberg F; Schmiegelow K
Med Pediatr Oncol; 2003 Feb; 40(2):82-7. PubMed ID: 12461790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
